Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.
teaser-1024x654-1

Thiacloprid API Manufacturers & Suppliers

0 verified results
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.

Commercial-scale Suppliers

No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Thiacloprid is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Thiacloprid or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Thiacloprid | CAS No: 111988-49-9 | GMP-certified suppliers

A medication that serves as an insecticide and pesticide for agricultural and industrial use, targeting pest control through neurotoxic effects on insects.

Therapeutic categories

AgrochemicalsCompounds used in a research, industrial, or household settingInsecticidesPesticidesSulfur CompoundsToxic Actions
Generic name
Thiacloprid
Molecule type
small molecule
CAS number
111988-49-9
DrugBank ID
DB08620
Approval status
Experimental drug

Product Snapshot

  • Thiacloprid is an oral small molecule formulation
  • Its primary use is as an experimental compound with pesticidal applications
  • Thiacloprid does not currently hold FDA or EMA approval for pharmaceutical use

Clinical Overview

Thiacloprid (CAS Number 111988-49-9) is an organic compound classified within the 2-halopyridine chemical class, characterized by a pyridine ring substituted at the 2-position with a halogen atom. It is principally utilized as an insecticide and pesticide in agricultural and industrial contexts. Thiacloprid is not approved for human therapeutic use and remains an experimental compound in pharmaceutical development.

From a pharmacological perspective, thiacloprid functions primarily as an agonist at insect nicotinic acetylcholine receptors (nAChRs). It disrupts nerve signal transmission in target insect species, leading to paralysis and death. This mechanism underpins its efficacy as an insecticidal agent, though its relevance to human pharmacology is limited.

Key ADME (absorption, distribution, metabolism, and excretion) parameters relevant to thiacloprid pertain mainly to environmental and toxicological assessments rather than clinical pharmacokinetics. The compound exhibits moderate persistence in environmental matrices, with metabolic biotransformation occurring in various organisms primarily through oxidative pathways. Data on mammalian metabolism and excretion are limited but highlight potential accumulation and toxicity concerns in non-target species.

Thiacloprid carries safety and toxicity considerations primarily related to its neurotoxic effects on insects and potential hazards to non-target organisms, including aquatic life and beneficial insects such as pollinators. Human exposure risks necessitate careful handling and adherence to regulatory guidelines to mitigate toxic actions. Its classification involves sulfur compound chemistry, contributing to its biological activity and environmental behavior.

The compound is found under various brand names and formulations globally as an agricultural pesticide, though regulatory approval status varies by region due to evolving environmental and toxicological data.

For API procurement, sourcing thiacloprid requires stringent quality controls to ensure purity and consistency, given its use in agrochemical formulations. Suppliers should comply with relevant industrial standards and regulatory frameworks governing pesticide manufacture and distribution. Analytical verification of chemical identity and absence of impurities is critical to maintain product safety and efficacy.

Identification & chemistry

Generic name Thiacloprid
Molecule type Small molecule
CAS 111988-49-9
UNII DSV3A944A4
DrugBank ID DB08620

Pharmacology

Targets
TargetOrganismActions
CHRNA7-FAM7A fusion proteinHumans

Formulation & handling

  • Thiacloprid is a small molecule suitable for oral formulation due to its moderate water solubility and LogP.
  • Handling of Thiacloprid should consider its solid state and potential sensitivity to moisture to maintain stability.
  • Its chemical classification as a 2-halopyridine suggests potential sensitivity to hydrolysis or photodegradation, requiring controlled storage conditions.

Regulatory status

Thiacloprid is a type of Insecticides


Insecticides are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to control and eradicate insects that pose a threat to human health, agricultural crops, and livestock. These potent chemicals play a crucial role in protecting our environment, ensuring food security, and preventing the spread of insect-borne diseases.

Pharmaceutical APIs in the insecticide category are designed to target specific insects, disrupting their nervous systems, inhibiting their growth, or interfering with their reproductive capabilities. These APIs are formulated into various insecticide formulations, including sprays, baits, powders, and granules, to suit different application methods and target pests.

Insecticides APIs are developed through rigorous research and development processes, adhering to stringent safety and efficacy standards set by regulatory authorities. These APIs undergo extensive testing to ensure their effectiveness, environmental impact, and potential risks to non-target organisms, such as humans and beneficial insects.

The pharmaceutical industry continually strives to enhance insecticide formulations by developing novel APIs with improved efficacy and reduced environmental toxicity. This includes exploring eco-friendly alternatives, such as biopesticides derived from natural sources like bacteria, fungi, or botanical extracts.

The demand for insecticide APIs is driven by the need to protect public health, agricultural productivity, and the global food supply chain. These APIs play a crucial role in controlling harmful insects, preventing economic losses, and mitigating the transmission of insect-borne diseases. Through ongoing research and innovation, the pharmaceutical industry aims to develop safer and more efficient insecticides that minimize environmental impact while effectively combating insect pests.